Want to see IN:QUICKHEAL full AI Analyst Report?
QUICKHEAL Stock Chart & Stats
₹155.00
₹1.01(0.65%)
At close: 4:00 PM EDT
₹155.00
₹1.01(0.65%)
Day’s Range― - ―
52-Week Range₹125.00 - ₹371.00
Previous CloseN/A
Volume64.67K
Average Volume (3M)72.37K
Market Cap
₹7.61B
Enterprise Value₹4.66K
Total Cash (Recent Filing)₹2.18B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)―
Beta1.84
Next Earnings
Oct 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.84
Shares Outstanding54,263,836
10 Day Avg. Volume143,023
30 Day Avg. Volume72,369
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)1.59
Price to Sales (P/S)2.65
P/FCF Ratio1.69K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage And Capital BufferNear-zero debt and substantial equity provide financial resilience while the company addresses operating weakness. The capital buffer can support product investment, channel activity and restructuring without the immediate interest burden or refinancing pressure associated with leveraged peers.
Diversified Cybersecurity Product ModelQuick Heal and Seqrite serve consumer and enterprise/government endpoints, reducing reliance on a single customer type. License, subscription, renewal and support revenue create an installed-base model that can support recurring demand when retention and product relevance remain strong.
Operating Cash Flow RecoveryOperating cash flow recovered to positive in FY2026 after the FY2025 downturn and had been positive in FY2023–FY2024. This indicates the business can still convert operations into cash, preserving flexibility, although consistency remains an important constraint.
Bears Say
Persistent Revenue ContractionRevenue declined about 4% in FY2025 and 6% in FY2026, signaling weakening demand, retention, pricing or channel execution. Sustained contraction would reduce the installed base and renewal opportunity, making it harder to spread product development and go-to-market costs.
Operating Losses And Margin PressureResults swung from the stronger FY2021–FY2022 period and FY2024 rebound into operating losses in FY2025 and deeper losses with a net loss in FY2026. Persistent margin pressure weakens internal funding capacity and raises execution risk.
Inconsistent Free Cash FlowCash generation is not dependable: operating cash flow and free cash flow turned negative in FY2025, while FY2026 free cash flow was only near breakeven. Limited surplus cash reduces room for sustained investment, acquisitions or shareholder returns.
Quick Heal Technologies Ltd. News
QUICKHEAL FAQ
What was Quick Heal Technologies Ltd.’s price range in the past 12 months?
Quick Heal Technologies Ltd. lowest stock price was ₹125.00 and its highest was ₹371.00 in the past 12 months.
What is Quick Heal Technologies Ltd.’s market cap?
Quick Heal Technologies Ltd.’s market cap is ₹7.61B.
When is Quick Heal Technologies Ltd.’s upcoming earnings report date?
Quick Heal Technologies Ltd.’s upcoming earnings report date is Oct 21, 2026 which is in 55 days.
How were Quick Heal Technologies Ltd.’s earnings last quarter?
Quick Heal Technologies Ltd. released its earnings results on Jul 30, 2026. The company reported -₹0.973 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Quick Heal Technologies Ltd. overvalued?
According to Wall Street analysts Quick Heal Technologies Ltd.’s price is currently Overvalued.
Does Quick Heal Technologies Ltd. pay dividends?
Quick Heal Technologies Ltd. pays a Annually dividend of ₹3 which represents an annual dividend yield of N/A. See more information on Quick Heal Technologies Ltd. dividends here
What is Quick Heal Technologies Ltd.’s EPS estimate?
Quick Heal Technologies Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Quick Heal Technologies Ltd. have?
Quick Heal Technologies Ltd. has 54,263,836 shares outstanding.
What happened to Quick Heal Technologies Ltd.’s price movement after its last earnings report?
Quick Heal Technologies Ltd. reported an EPS of -₹0.973 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.094%.
Which hedge fund is a major shareholder of Quick Heal Technologies Ltd.?
Currently, no hedge funds are holding shares in IN:QUICKHEAL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Quick Heal Technologies Ltd.
Quick Heal Technologies Limited, an Indian company established in Pune in 1995, specializes in providing cybersecurity software and solutions. The firm caters to a diverse clientele, including individual consumers, small and medium-sized businesses, government bodies, and large corporations, serving both the domestic Indian market and international clients. Its business is divided into three key operating segments: Retail, Enterprise & Government, and Mobile. Among its core product offerings are GoDeep.AI, an advanced engine for detecting malware; Seqrite Hawk, a comprehensive cybersecurity platform; and Hawk Eye, a sophisticated cloud-based platform designed for centralized enterprise security management. Quick Heal also delivers vital technical and post-sales support services. Its products, all branded under Seqrite, reach customers through an extensive network of service providers, system integrators, resellers, and distributors.
Technical Analysis
eMudhra Limited
―
Kellton Tech Solutions Ltd.
―
Ksolves India Ltd
―
SecureKloud Technologies Limited
―
Subex Limited
―